Texas House Bill HB1640

Texas 2021 - 87th Regular

Caption

Relating to a medication-assisted treatment program established by the Texas Department of Criminal Justice for inmates with opioid use disorders.

Impact

The legislation is positioned to significantly impact how opioid dependence is managed within correctional facilities in Texas. By ensuring that inmates have access to medication-assisted treatment, the bill seeks to provide a structured support system throughout their incarceration and into their transition back into society. This approach aims to reduce recidivism and promote overall public health, acknowledging the challenges posed by opioid addiction and the necessity for effective treatment options within the prison system.

Summary

House Bill 1640 aims to establish a medication-assisted treatment program for inmates with opioid use disorders under the Texas Department of Criminal Justice. The bill underscores the importance of assessing each inmate for opioid dependence during the diagnostic process, and if diagnosed with an opioid use disorder, inmates will be provided the opportunity to receive medication-assisted treatment as part of their rehabilitation. The treatment combines approved medications from the FDA with counseling and behavioral therapies, tailored specifically to each individual's needs.

Contention

One potential point of contention surrounding HB 1640 lies in the logistics of implementation, including funding and availability of qualified treatment providers. While the bill demonstrates a progressive shift towards addressing substance abuse issues within the criminal justice system, there may be disagreements on how to effectively execute these programs and ensure they reach all affected inmates. Additionally, concerns regarding the potential stigma related to providing such treatments in prison could also arise, impacting both policy acceptance and inmate participation.